Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.71 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.71 |
| ▸ | POLB | P06746 | 3/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.62 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL178366 | 0.93 | MAPK14 (0.75) | MAPK14LMNAHDAC6HDAC1POLB | |
| SCHEMBL13932522 | 0.91 | ALDH1A1 (0.78) | MAPK14LMNAHDAC6HDAC1POLB | |
| SCHEMBL1927145 | 0.90 | EPHX2 (0.77) | MAPK14LMNAHDAC6HDAC1POLB | |
| SCHEMBL457082 | 0.87 | HDAC6 (0.79) | LMNAHDAC6HDAC1ALDH1A1HPGD | |
| SCHEMBL31061058 | 0.86 | MAPK14 (1.00) | MAPK14LMNASMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL1927512 | 0.86 | EPHX2 (0.77) | MAPK14LMNAHDAC6HDAC1SMN1; SMN2 | |
| SCHEMBL19358924 | 0.86 | MAPT (0.74) | LMNAPOLBSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL15985750 | 0.85 | MAPK14 (0.65) | MAPK14LMNAHDAC6HDAC1POLB | |
| Hydrochloric Acid SCHEMBL3757721 | 0.85 | HDAC6 (0.76) | LMNAHDAC6HDAC1ALDH1A1HPGD | |
| SCHEMBL29184442 | 0.85 | HDAC6 (0.76) | LMNAHDAC6HDAC1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115505278-B | Recycled plant composite fiber and preparation method thereof | 陆进貌 | 2024-09-27 | — | — | CN | claimed |
| CN-118390297-A | Preparation method of recycled plant composite fiber | 陆进貌 | 2024-07-26 | — | — | CN | claimed |
| CN-108884021-A | Novel compound having HSP90 inhibitory activity or pharmaceutically acceptable salt thereof and medical use thereof | 启明大学校产学协力团 | 2018-11-23 | — | — | CN | claimed |
| CN-115505278-B | Recycled plant composite fiber and preparation method thereof | 陆进貌 | 2024-09-27 | — | — | CN | disclosed |
| CN-115505278-B | Recycled plant composite fiber and preparation method thereof | 陆进貌 | 2024-09-27 | — | — | CN | disclosed |
| CN-118390297-A | Preparation method of recycled plant composite fiber | 陆进貌 | 2024-07-26 | — | — | CN | disclosed |
| CN-118390297-A | Preparation method of recycled plant composite fiber | 陆进貌 | 2024-07-26 | — | — | CN | disclosed |
| CN-117243839-A | Minoxidil adjuvant therapy | 应用生物学股份有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-115505278-A | Recycled plant composite fiber and preparation method thereof | 陆进貌 | 2022-12-23 | — | — | CN | disclosed |
| CN-115505278-A | Recycled plant composite fiber and preparation method thereof | 陆进貌 | 2022-12-23 | — | — | CN | disclosed |
| CN-108884021-A | Novel compound having HSP90 inhibitory activity or pharmaceutically acceptable salt thereof and medical use thereof | 启明大学校产学协力团 | 2018-11-23 | — | — | CN | disclosed |
| US-20140120087-A1 | TRIAZOLOPYRIDINES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-05-01 | — | — | US | disclosed |
| CN-103113176-A | Method for synthesizing N-alkenamide | UNIV NANJING SCIENCE & TECH | 2013-05-22 | — | — | CN | disclosed |
| EP-1523473-B1 | INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA (DE) | 2013-02-27 | — | — | EP | disclosed |
| US-8093227-B2 | Monosaccharide compounds and methods therefor | ALCHEMIA PTY LTD (AU) | 2012-01-10 | — | — | US | disclosed |
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | ALCHEMIA PTY LTD. (AU) | 2010-07-22 | — | — | US | disclosed |
| US-7417129-B2 | Combinatorial libraries of monosaccharides | ALCHEMIA PTY LTD (AU) | 2008-08-26 | — | — | US | disclosed |
| US-5314880-A | Platelet activating factor antagonist | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1994-05-24 | — | — | US | disclosed |
| EP-0468971-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1992-02-05 | — | — | EP | disclosed |
| WO-1990009997-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1990-09-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140120087-A1 | TRIAZOLOPYRIDINES | QDPR, TBXA2R, KCNJ11 | MAPK14 4701/4885LMNA 1537/4885HDAC6 2900/4885 |
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | SLC5A1, UGGT1, MRPL21 | MAPK14 567/4885LMNA 4069/4885HDAC6 764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.